Cardiovascular consequences of obesity

Drug Discovery Today: Therapeutic Strategies

Volumn 5, Issue 1, 2008, Pages 45-51

  Poirier, Paul ^a   Eckel, Robert H ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANDOLAPRIL;

ABDOMINAL OBESITY; ACUTE HEART INFARCTION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ATHEROGENESIS; BARIATRIC SURGERY; BEHAVIOR THERAPY; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIET THERAPY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MORTALITY; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; POSTOPERATIVE COMPLICATION; PROGNOSIS; QT INTERVAL; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; WAIST HIP RATIO; WEIGHT REDUCTION;

EID: 57349200428     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2008.05.005     Document Type: Review

References (83)

1. Poirier P., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006) 898-918
2. Guidelines for reporting results in bariatric surgery. Standards Committee, American Society for Bariatric Surgery. Obes. Surg. 7 (1997) 521-522
3. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch. Intern. Med. 163 (2003) 2146-2148
4. Despres J.P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
5. Eckel R.H., et al. The metabolic syndrome. Lancet 365 (2005) 1415-1428
6. Poirier P., and Despres J.P. Waist circumference, visceral obesity, and cardiovascular risk. J. Cardiopulm. Rehabil. 23 (2003) 161-169
7. Kahn R., et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 28 (2005) 2289-2304
8. Eckel R.H., and Krauss R.M. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 97 (1998) 2099-2100
9. Ogden C.L., et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288 (2002) 1728-1732
10. Teixeira P.J., et al. Total and regional fat and serum cardiovascular disease risk factors in lean and obese children and adolescents. Obes. Res. 9 (2001) 432-442
11. Olshansky S.J., et al. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 352 (2005) 1138-1145
12. Fontaine K.R., et al. Years of life lost due to obesity. JAMA 289 (2003) 187-193
13. Poirier P. Adiposity and cardiovascular disease: are we using the right definition of obesity?. Eur. Heart J. 28 (2007) 2047-2048
14. Yusuf S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
15. Yusuf S., et al. Tackling the challenge of cardiovascular disease burden in developing countries. Am. Heart J. 148 (2004) 1-4
16. Poirier P. Recurrent cardiovascular events in contemporary cardiology: obesity patients should not rest in PEACE. Eur. Heart J. 27 (2006) 1390-1391
17. Lemieux I., et al. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can. J. Cardiol. 18 (2002) 725-732
18. Tanko L.B., et al. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 111 (2005) 1883-1890
19. Isomaa B., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
20. Lakka H.M., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
21. Girman C.J., et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am. J. Cardiol. 93 (2004) 136-141
22. Malik S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
23. Cheng T.O. Bulging waistline is a more sensitive predictor of cardiovascular diseases than body mass index in the Chinese population. Nutr. Rev. 62 (2004) 448
24. Pi-Sunyer F.X. The epidemiology of central fat distribution in relation to disease. Nutr. Rev. 62 (2004) S120-S126
25. Kurth T., et al. Body mass index and the risk of stroke in men. Arch. Intern. Med. 162 (2002) 2557-2562
26. McGill H.C. Fatty streaks in the coronary arteries and aorta. Lab. Invest. 18 (1968) 560-564
27. Skalen K., et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417 (2002) 750-754
28. Zieske A.W., et al. Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr. Pathol. Mol. Med. 21 (2002) 213-237
29. Kortelainen M.L., and Sarkioja T. Visceral fat and coronary pathology in male adolescents. Int. J. Obes. Relat. Metab. Disord. 25 (2001) 228-232
30. Kondo I., et al. Ultrasonographic assessment of coronary flow reserve and abdominal fat in obesity. Ultrasound Med. Biol. 27 (2001) 1199-1205
31. Amano T., et al. Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions integrated backscatter intravascular ultrasound study. J. Am. Coll. Cardiol. 49 (2007) 1149-1156
32. Achimastos A.D., et al. Arterial stiffness: determinants and relationship to the metabolic syndrome. Angiology 58 (2007) 11-20
33. Rutkowski P., et al. Renal disease in obesity: the need for greater attention. J. Ren. Nutr. 16 (2006) 216-223
34. Lakka T.A., et al. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis 154 (2001) 497-504
35. Dagenais G.R., et al. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am. Heart J. 149 (2005) 54-60
36. Kragelund C., et al. Impact of obesity on long-term prognosis following acute myocardial infarction. Int. J. Cardiol. 98 (2005) 123-131
37. Buettner H.J., et al. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur. Heart J. 28 (2007) 1694-1701
38. Romero-Corral A., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666-678
39. Gami A.S., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49 (2007) 403-414
40. Wang F., et al. The relationship between National Heart, Lung, and Blood Institute Weight Guidelines and concurrent medical costs in a manufacturing population. Am. J. Health Promot. 17 (2003) 183-189
41. Cornier M.A., et al. Relationship between waist circumference, body mass index, and medical care costs. Obes. Res. 10 (2002) 1167-1172
42. Iacobellis G., and Sharma A.M. Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr. Pharm. Des. 13 (2007) 2180-2184
43. Vela D., et al. The role of periadventitial fat in atherosclerosis. Arch. Pathol. Lab. Med. 131 (2007) 481-487
44. Ishii T., et al. The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J. Pathol. 185 (1998) 4-9
45. Ishikawa Y., et al. Absence of atherosclerosis evolution in the coronary arterial segment covered by myocardial tissue in cholesterol-fed rabbits. Virchows Arch. 430 (1997) 163-171
46. Baker A.R., et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc. Diabetol. 5 (2006) 1
47. Otsuka Y., et al. Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty. Eur. Heart J. 21 (2000) 1790-1796
48. St Pierre J., et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am. J. Cardiol. 90 (2002) 15-18
49. Rana J.S., et al. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention. Diabetes Care 28 (2005) 873-877
50. Rana J.S., et al. Obesity and clinical restenosis after coronary stent placement. Am. Heart J. 150 (2005) 821-826
51. Bernstein A.D., and Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann. Thorac. Surg. 69 (2000) 823-828
52. Ascione R., and Angelini G.D. Is obesity still a risk factor for patients undergoing coronary surgery?. Ital. Heart J. 4 (2003) 824-828
53. Rockx M.A., et al. Is obesity a predictor of mortality, morbidity and readmission after cardiac surgery?. Can. J. Surg. 47 (2004) 34-38
54. Moulton M.J., et al. Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation 94 (1996) II87-II92
55. Birkmeyer N.J., et al. Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 97 (1998) 1689-1694
56. Kuduvalli M., et al. Risk of morbidity and in-hospital mortality in obese patients undergoing coronary artery bypass surgery. Eur. J. Cardiothorac. Surg. 22 (2002) 787-793
57. Maurer M.S., et al. The effect of body mass index on complications from cardiac surgery in the oldest old. J. Am. Geriatr. Soc. 50 (2002) 988-994
58. Wigfield C.H., et al. Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI > or = 40. Eur. J. Cardiothorac. Surg. 29 (2006) 434-440
59. Villavicencio M.A., et al. Cardiac surgery in patients with body mass index of 50 or greater. Ann. Thorac. Surg. 83 (2007) 1403-1411
60. Korpilahti K., et al. Components of the insulin resistance syndrome are associated with progression of atherosclerosis in non-grafted arteries 5 years after coronary artery bypass surgery. Eur. Heart J. 19 (1998) 711-719
61. Echahidi N., et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J. Am. Coll. Cardiol. 50 (2007) 843-851
62. Echahidi N., et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 116 (2007) I213-I219
63. Katz R., et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 113 (2006) 2113-2119
64. Briand M., et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J. Am. Coll. Cardiol. 47 (2006) 2229-2236
65. Briand M., et al. Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation 114 (2006) I512-I517
66. Nicklas B.J., et al. Abdominal obesity is an independent risk factor for chronic heart failure in older people. J. Am. Geriatr. Soc. 54 (2006) 413-420
67. Brown C.D., et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes. Res. 8 (2000) 605-619
68. Quan S.F., and Gersh B.J. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation 109 (2004) 951-957
69. Unger R.H. Hyperleptinemia: protecting the heart from lipid overload. Hypertension 45 (2005) 1031-1034
70. McGavock J.M., et al. Adiposity of the heart, revisited. Ann. Intern. Med. 144 (2006) 517-524
71. Hunt S.A., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation 104 (2001) 2996-3007
72. Remme W.J., and Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22 (2001) 1527-1560
73. Corbi G.M., et al. FFAs and QT intervals in obese women with visceral adiposity: effects of sustained weight loss over 1 year. J. Clin. Endocrinol. Metab. 87 (2002) 2080-2083
74. Ector J., et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J. Am. Coll. Cardiol. 50 (2007) 234-242
75. Poirier P., and Despres J.P. Exercise in weight management of obesity. Cardiol. Clin. 19 (2001) 459-470
76. Kraus W.E., et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med. 347 (2002) 1483-1492
77. Klein S., et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 110 (2004) 2952-2967
78. Drolet B., et al. Impact of weight-loss medications on the cardiovascular system: focus on current and future anti-obesity drugs. Am. J. Cardiovasc. Drugs 7 (2007) 273-288
79. Ryan D.H., et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin. Trials 24 (2003) 610-628
80. Ribisl P.M., et al. Exercise capacity and cardiovascular/metabolic characteristics of overweight and obese individuals with type 2 diabetes: the Look AHEAD clinical trial. Diabetes Care 30 (2007) 2679-2684
81. Bray G.A. The missing link - lose weight, live longer. N. Engl. J. Med. 357 (2007) 818-820
82. Sjostrom L., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357 (2007) 741-752
83. Adams T.D., et al. Long-term mortality after gastric bypass surgery. N. Engl. J. Med. 357 (2007) 753-761